FDA approves Keytruda for skin cancer patients with inoperable melanoma

October 27, 2014 11:37 AM

15 0

It's 10:30 on Wednesday morning and Carl Paulk is waiting patiently in a large lounge chair in the Clinical Research Unit at H. Lee Moffitt Cancer Center. He makes the one-hour drive to Tampa every three weeks to have his blood drawn, see his doctor and wait for the okay to receive another dose of hope — a new drug called Keytruda.

Keytruda was granted special Food and Drug Administration clearance last month to be given to certain melanoma patients whose cancer worsens after standard treatment. The drug performed so well early in clinical trials that approval was granted before testing is officially completed.

Read more

To category page